세계 의약품 블리스터 포장 시장의 예측(-2030년) : 제품 유형별, 재료별, 기술별, 용도별, 최종 사용자별, 지역별 분석

According to Stratistics MRC, the Global Pharmaceutical Blister Packaging Market is accounted for $12.08 billion in 2024 and is expected to reach $18.44 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Pharmaceutical blister packaging serves as a primary packaging method for safeguarding and preserving medications. It typically consists of a pre-formed plastic cavity (blister) that holds individual doses of pills or capsules, sealed with a backing material such as foil. This packaging method ensures dosage accuracy, protects against environmental factors, and provides tamper-evidence, making it essential for maintaining drug integrity and safety.

According to the National Center for Biotechnology Information (NCBI), the pharmaceutical packaging market has experienced annual growth of at least five percent per year in recent years. The market is now estimated to be worth over $20 billion a year.

Market Dynamics:

Driver:

Growing demand for convenient and safe packaging

The increasing demand for convenient and safe packaging in the pharmaceutical industry is driving the growth of the blister packaging market. Blister packs offer tamper-evident protection, extend shelf life, and provide easy dispensing of individual doses. They also enhance patient compliance by organizing medications in a clear, visible manner. As consumers and healthcare providers prioritize safety and ease of use, pharmaceutical companies are adopting blister packaging solutions to meet these needs, thereby fueling market expansion.

Restraint:

High cost of raw materials

Materials like PVC, aluminum foil, and barrier films are subject to price fluctuations and supply chain disruptions. These costs are often passed on to consumers, potentially affecting affordability and accessibility of medications. Additionally, the need for specialized equipment and processes for blister pack production further increases overall costs. This financial barrier may limit adoption, particularly among smaller pharmaceutical companies or in price-sensitive markets.

Opportunity:

Rising pharmaceutical production

The rising pharmaceutical production worldwide presents a significant opportunity for the blister packaging market. As drug manufacturers increase output to meet growing healthcare demands, the need for efficient and reliable packaging solutions escalates. Blister packaging offers advantages in terms of product protection, dosage control, and manufacturing efficiency. This trend is particularly pronounced in emerging markets where pharmaceutical industries are rapidly expanding. The opportunity lies in developing innovative, cost-effective blister packaging solutions that can keep pace with the growing pharmaceutical production volumes.

Threat:

Alternative packaging solutions

The threat of alternative packaging solutions poses a challenge to the pharmaceutical blister packaging market. Innovations in bottle packaging, stick packs, and pouches offer competing options that may be more suitable for certain medications or preferred by some consumers. Additionally, sustainable packaging trends are driving the development of eco-friendly alternatives that could potentially replace traditional blister packs.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted supply chains but subsequently boosted demand for pharmaceutical packaging. Increased focus on healthcare and medication led to higher production of drugs, driving demand for blister packaging. The pandemic also accelerated trends towards tamper-evident and hygiene-focused packaging solutions, benefiting the blister packaging market.

The plastic films segment is expected to be the largest during the forecast period

The plastic films segment's dominance in the pharmaceutical blister packaging market is driven by its versatility, cost-effectiveness, and barrier properties. Plastic films, particularly PVC and PET, offer excellent moisture protection and are compatible with various forming and sealing processes. They allow for clear visibility of the product, enhancing consumer confidence. The segment's growth is further fueled by innovations in high-barrier films that extend product shelf life. As pharmaceutical companies seek efficient, protective packaging solutions, plastic films continue to be the preferred choice, contributing significantly to market expansion.

The laser cutting segment is expected to have the highest CAGR during the forecast period

The laser cutting segment's high CAGR in the pharmaceutical blister packaging market is attributed to its precision, efficiency, and adaptability to complex designs. Laser cutting technology allows for intricate shapes and perforations, enhancing package functionality and ease of use. It offers advantages in terms of reduced material waste and increased production speeds compared to traditional cutting methods. The growing demand for customized, patient-friendly packaging designs is driving the adoption of laser cutting. This technology's ability to meet stringent quality standards and support innovative packaging solutions is fueling its rapid growth in the market.

Region with largest share:

North America's dominance in the pharmaceutical blister packaging market is driven by its robust pharmaceutical industry, stringent regulations, and high healthcare expenditures. The region's focus on patient safety and drug integrity aligns well with the benefits of blister packaging. The presence of major pharmaceutical companies and packaging manufacturers contributes to continuous innovation in this sector. Additionally, the growing aging population and increasing prevalence of chronic diseases in North America are boosting demand for prescription medications, further driving the blister packaging market. The region's advanced healthcare infrastructure also supports the adoption of sophisticated packaging solutions.

Region with highest CAGR:

The Asia Pacific region's rapid growth in the pharmaceutical blister packaging market is fueled by several factors. The expanding pharmaceutical industry, particularly in countries like China and India, is driving demand for advanced packaging solutions. Rising healthcare awareness, increasing disposable incomes, and growing populations are contributing to higher medication consumption. Government initiatives to improve healthcare access are also boosting pharmaceutical production. Additionally, the region's emerging economies are attracting investments in pharmaceutical manufacturing and packaging technologies, propelling growth in the Asia Pacific region.

Key players in the market

Some of the key players in Pharmaceutical Blister Packaging market include Amcor plc, WestRock Company, and Constantia Flexibles, alongside other significant contributors like Klockner Pentaplast Group, Honeywell International Inc., Bemis Company Inc., ACG Pharmapack Pvt. Ltd., Sonoco Products Company, Bilcare Research Inc., Winpak Ltd., Uflex Ltd., RENOLIT SE, Tekni-Plex, Inc., Carcano Antonio S.p.A., Caprihans India Limited, The Dow Chemical Company, DuPont de Nemours, Inc., and PCI Pharma Services.

Key Developments:

In July 2022, Honeywell's Aclar range of barrier film blisters received technical recyclability recognition from TerraCycle, marking a milestone in pharmaceutical packaging recyclability.

In April 2021, Amcor announced customer trials for AmSky, the world's first recyclable polyethylene-based thermoform blister packaging. It's designed to meet stringent pharmaceutical packaging requirements while being recyclable.

In February 2020, Sonoco's Alloyd division introduced EnviroSense PaperBlister, an all-paper retail blister package as an environmentally friendly alternative to thermoformed plastic blister packages.

Product Types Covered:

• Carded
• Clamshell

Materials Covered:

• Plastic Films
• Aluminum
• Paper & Paperboard
• Biodegradable Materials

Technologies Covered:

• Thermoforming
• Cold Forming
• Heat Sealing
• Laser Cutting
• Other Technologies

Applications Covered:

• Tablets & Capsules
• Syringes & Ampoules
• Syrups
• Ointments
• Medical Devices
• Patches

End Users Covered:

• Hospitals & Clinics
• Retail Pharmacies
• Pharmaceutical Companies
• Contract Packaging Organizations (CPOs)
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pharmaceutical Blister Packaging Market, By Product Type

• 5.1 Introduction
• 5.2 Carded
• 5.3 Clamshell

6 Global Pharmaceutical Blister Packaging Market, By Material

• 6.1 Introduction
• 6.2 Plastic Films
  • 6.2.1 Polyvinyl Chloride (PVC)
  • 6.2.2 Polyvinylidene Chloride (PVDC)
  • 6.2.3 Polyethylene Terephthalate (PET)
  • 6.2.4 Polypropylene (PP)
  • 6.2.5 Polyethylene (PE)
  • 6.2.6 Nylon
  • 6.2.7 Others Plastic Films
• 6.3 Aluminum
• 6.4 Paper & Paperboard
• 6.5 Biodegradable Materials

7 Global Pharmaceutical Blister Packaging Market, By Technology

• 7.1 Introduction
• 7.2 Thermoforming
• 7.3 Cold Forming
• 7.4 Heat Sealing
• 7.5 Laser Cutting
• 7.6 Other Technologies

8 Global Pharmaceutical Blister Packaging Market, By Application

• 8.1 Introduction
• 8.2 Tablets & Capsules
• 8.3 Syringes & Ampoules
• 8.4 Syrups
• 8.5 Ointments
• 8.6 Medical Devices
• 8.7 Patches

9 Global Pharmaceutical Blister Packaging Market, By End User

• 9.1 Introduction
• 9.2 Hospitals & Clinics
• 9.3 Retail Pharmacies
• 9.4 Pharmaceutical Companies
• 9.5 Contract Packaging Organizations (CPOs)
• 9.6 Other End Users

10 Global Pharmaceutical Blister Packaging Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Amcor plc
• 12.2 WestRock Company
• 12.3 Constantia Flexibles
• 12.4 Klockner Pentaplast Group
• 12.5 Honeywell International Inc.
• 12.6 Bemis Company Inc.
• 12.7 ACG Pharmapack Pvt. Ltd.
• 12.8 Sonoco Products Company
• 12.9 Bilcare Research Inc.
• 12.10 Winpak Ltd.
• 12.11 Uflex Ltd.
• 12.12 RENOLIT SE
• 12.13 Tekni-Plex, Inc.
• 12.14 Carcano Antonio S.p.A.
• 12.15 Caprihans India Limited
• 12.16 The Dow Chemical Company
• 12.17 DuPont de Nemours, Inc.
• 12.18 PCI Pharma Services